PLAT (P00750) variants and mutations
PLAT (also known as P00750) is a human protein-coding gene encoding a tissue-type plasminogen activator protein. It converts plasminogen to plasmin preferentially on fibrin surfaces, promoting breakdown of established blood clots. Recombinant tissue plasminogen activator is used therapeutically for selected acute ischemic strokes and thrombotic emergencies, balanced against bleeding risk. This analysis covers 966 PLAT variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes pulmonary embolism, myocardial infarction, and hemorrhage. Example PLAT variants include D2H, D2N, and M4T.
Variant analysis overview
- Gene: PLAT
- Protein: P00750
- UniProt accession: P00750
- Organism: Homo sapiens
- Variants analyzed: 966
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 738 unspecified-consequence records; 1 stop lost; 93 synonymous variants; 106 missense variants; 13 frameshift variants; 5 stop-gained variants; 5 splice-region variants; 6 in-frame deletions; 2 substitution
- Prediction scores: 740 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: pulmonary embolism, myocardial infarction, hemorrhage, acute myocardial infarction, stroke disorder, Recurrent thrombophlebitis, heart failure, ST Elevation Myocardial Infarction, ischemic stroke, Stroke, congestive heart failure, hemorrhagic disease.
Protein structure and variant hotspots
- Protein features: 5 domains; 4 post-translational modification sites.
- Structural context: 872 variants have structural context.
- PTM context: 8 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PLAT variants
Examples include D2H, D2N, M4T, K5*, R6G, R6K, R6T, G7A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- D2H (p.Asp2His), TOPMed rs1486658996, gnomAD rs1486658996
- D2N (p.Asp2Asn), TOPMed rs1486658996, gnomAD rs1486658996, REVEL 0.32, CADD 0.38
- M4T (p.Met4Thr), TOPMed rs1805752059, REVEL 0.35, CADD 14.30
- K5* (p.Lys5Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R6G (p.Arg6Gly), TOPMed rs1805751751, gnomAD rs1805751751, REVEL 0.54, CADD 10.30
- R6K (p.Arg6Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R6T (p.Arg6Thr), gnomAD rs1215325474, REVEL 0.54, CADD 0.55
- G7A (p.Gly7Ala), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54275, Variant assessed as somatic; moderate impact.
- G7E (p.Gly7Glu), Ensembl rs1945680057, REVEL 0.49, CADD 0.20
- G7R (p.Gly7Arg), gnomAD rs1485707068, REVEL 0.53, CADD 7.20
- L8F (p.Leu8Phe), gnomAD rs1805751356, REVEL 0.23, CADD 9.80
- L12M (p.Leu12Met), 1000Genomes rs139638584, ESP rs139638584, ExAC rs139638584, TOPMed rs139638584, REVEL 0.35, CADD 14.70
- L13P (p.Leu13Pro), TOPMed rs962301004, gnomAD rs962301004, REVEL 0.76, CADD 25.00
- G16A (p.Gly16Ala), ExAC rs780605910, TOPMed rs780605910, gnomAD rs780605910
- G16E (p.Gly16Glu), ExAC rs780605910, TOPMed rs780605910, gnomAD rs780605910, REVEL 0.54, CADD 17.00
- G16R (p.Gly16Arg), TOPMed rs1015144994, gnomAD rs1015144994, REVEL 0.48, CADD 23.00
- A17G (p.Ala17Gly), gnomAD rs1259212803
- A17V (p.Ala17Val), gnomAD rs1259212803, REVEL 0.18, CADD 4.63
- V18A (p.Val18Ala), ExAC rs745384030, TOPMed rs745384030, gnomAD rs745384030, REVEL 0.28, CADD 1.65, Uncertain significance, not specified
- V18L (p.Val18Leu), TOPMed rs1489185170, gnomAD rs1489185170, REVEL 0.11, CADD 5.98
- F19L (p.Phe19Leu), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54278, ESP rs141964626, ExAC rs141964626, REVEL 0.31, CADD 8.43, Likely benign
- V20G (p.Val20Gly), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99534, Variant assessed as somatic; moderate impact.
- V20I (p.Val20Ile), rs753589968, NCI-TCGA Cosmic COSV5427, cosmic curated COSV54279, ExAC rs753589968, REVEL 0.29, CADD 0.28, Variant assessed as somatic; moderate impact.
- V20L (p.Val20Leu), ExAC rs753589968, TOPMed rs753589968, gnomAD rs753589968, REVEL 0.41, CADD 0.63
- S21L (p.Ser21Leu), ExAC rs777690688, TOPMed rs777690688, gnomAD rs777690688, REVEL 0.46, CADD 0.02
- P22L (p.Pro22Leu), cosmic curated COSV10501
- P22T (p.Pro22Thr), cosmic curated COSV54275
- S23R (p.Ser23Arg), cosmic curated COSV54274, Ensembl rs1563260652, REVEL 0.48, CADD 11.60
- Q24* (p.Gln24Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q24H (p.Gln24His), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54275, Variant assessed as somatic; moderate impact.
- E25K (p.Glu25Lys), TOPMed rs1257214193, gnomAD rs1257214193, REVEL 0.38, CADD 21.20
- I26V (p.Ile26Val), TOPMed rs1214042840, gnomAD rs1214042840, REVEL 0.18, CADD 4.59
- A28T (p.Ala28Thr), Ensembl rs1805679853
- R29* (p.Arg29Ter), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54275, TOPMed rs1244225099, gnomAD rs1244225099, CADD 35.00, Variant assessed as somatic; high impact.
- R29G (p.Arg29Gly), TOPMed rs1244225099, gnomAD rs1244225099, REVEL 0.50, CADD 23.30
- R29Q (p.Arg29Gln), cosmic curated COSV99535, ESP rs367949901, ExAC rs367949901, gnomAD rs367949901, REVEL 0.21, CADD 18.50, Uncertain significance, not specified
- F30L (p.Phe30Leu), cosmic curated COSV54274
- F30Y (p.Phe30Tyr), Ensembl rs1587937924, REVEL 0.17, CADD 17.20
- R32K (p.Arg32Lys), NCI-TCGA TCGA novel, NCI-TCGA Cosmic COSV5427, Variant assessed as somatic; high impact.
- R32T (p.Arg32Thr), rs1390184489, NCI-TCGA Cosmic COSV5427, cosmic curated COSV54277, gnomAD rs1390184489, REVEL 0.70, CADD 32.00, Variant assessed as somatic; moderate impact.
- G33A (p.Gly33Ala), gnomAD rs1327030828, REVEL 0.67, CADD 27.50
- G33E (p.Gly33Glu), gnomAD rs1327030828, REVEL 0.73, CADD 27.40
- G33R (p.Gly33Arg), ExAC rs781130644, TOPMed rs781130644, gnomAD rs781130644, REVEL 0.70, CADD 23.90
- A34D (p.Ala34Asp), rs8178733, ClinGen CA4731465, ClinVar RCV000885945, UniProt VAR 020181, REVEL 0.50, CADD 24.40, Likely benign, not provided
- R35K (p.Arg35Lys), cosmic curated COSV10958
- R35IfsX9, rs886041071, Uncertain significance
- S36A (p.Ser36Ala), TOPMed rs1396290576, gnomAD rs1396290576
- S36T (p.Ser36Thr), TOPMed rs1396290576, gnomAD rs1396290576, REVEL 0.30, CADD 21.60
- Y37* (p.Tyr37Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V39A (p.Val39Ala), 1000Genomes rs780104546, ExAC rs780104546, gnomAD rs780104546, REVEL 0.27, CADD 0.00
- V39E (p.Val39Glu), 1000Genomes rs780104546, ExAC rs780104546, gnomAD rs780104546, REVEL 0.49, CADD 0.01
- V39L (p.Val39Leu), TOPMed rs1446229320, REVEL 0.41, CADD 34.00
- C41A (p.Cys41Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R42T (p.Arg42Thr), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99535, Variant assessed as somatic; moderate impact.
- D43E (p.Asp43Glu), TOPMed rs1197841254, gnomAD rs1197841254, REVEL 0.35, CADD 8.24
- E44D (p.Glu44Asp), gnomAD rs1264091169, REVEL 0.09, CADD 3.11
- E44K (p.Glu44Lys), rs757271387, ClinGen CA4731443, ClinVar RCV004224955, ExAC rs757271387, REVEL 0.17, CADD 18.40, Uncertain significance, not specified
- K45N (p.Lys45Asn), TOPMed rs1203524924, gnomAD rs1203524924, REVEL 0.09, CADD 8.15
- T46M (p.Thr46Met), rs375926300, NCI-TCGA Cosmic COSV5427, cosmic curated COSV54276, ESP rs375926300, REVEL 0.37, CADD 24.30, Variant assessed as somatic; moderate impact.
- T46R (p.Thr46Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q47* (p.Gln47Ter), TOPMed rs1213656235, gnomAD rs1213656235, CADD 36.00
- M48I (p.Met48Ile), ExAC rs756298909, TOPMed rs756298909, gnomAD rs756298909, REVEL 0.12, CADD 15.40
- Y50C (p.Tyr50Cys), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54278, Variant assessed as somatic; moderate impact.
- Y50H (p.Tyr50His), cosmic curated COSV54274, ExAC rs753017094, TOPMed rs753017094, gnomAD rs753017094, REVEL 0.57, CADD 21.80
- Q51* (p.Gln51Ter), TOPMed rs1473282981, gnomAD rs1473282981, CADD 35.00
- Q51L (p.Gln51Leu), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54274, Variant assessed as somatic; moderate impact.
- H53Q (p.His53Gln), TOPMed rs1397665499, gnomAD rs1397665499, REVEL 0.07, CADD 0.01
- H53Y (p.His53Tyr), ESP rs142945501, TOPMed rs142945501, gnomAD rs142945501, REVEL 0.10, CADD 13.30
- Q54* (p.Gln54Ter), cosmic curated COSV54274, CADD 32.00
- S55L (p.Ser55Leu), Ensembl rs1805590694
- S55P (p.Ser55Pro), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99535, Variant assessed as somatic; moderate impact.
- W56R (p.Trp56Arg), cosmic curated COSV54275, REVEL 0.79, CADD 25.80
- L57M (p.Leu57Met), ExAC rs774656820, gnomAD rs774656820, REVEL 0.28, CADD 24.10
- R58C (p.Arg58Cys), ExAC rs767004270, TOPMed rs767004270, gnomAD rs767004270, REVEL 0.62, CADD 26.70
- R58H (p.Arg58His), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54277, Ensembl rs1805590323, REVEL 0.46, CADD 25.00, Variant assessed as somatic; moderate impact.
- R58P (p.Arg58Pro), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54276, Variant assessed as somatic; moderate impact.
- R58S (p.Arg58Ser), ExAC rs767004270, TOPMed rs767004270, gnomAD rs767004270, REVEL 0.53, CADD 24.90
- P59L (p.Pro59Leu), TOPMed rs1587936145, REVEL 0.18, CADD 24.30
- P59S (p.Pro59Ser), ExAC rs762501048, gnomAD rs762501048, REVEL 0.32, CADD 24.00
- V60E (p.Val60Glu), 1000Genomes rs532003804, ExAC rs532003804, TOPMed rs532003804, gnomAD rs532003804, REVEL 0.15, CADD 7.61
- L61F (p.Leu61Phe), Ensembl rs1587936133
- R62K (p.Arg62Lys), cosmic curated COSV54274, REVEL 0.29, CADD 16.30
- S63I (p.Ser63Ile), ExAC rs769465426, TOPMed rs769465426, gnomAD rs769465426, REVEL 0.19, CADD 17.70
- R65Q (p.Arg65Gln), 1000Genomes rs202117167, ExAC rs202117167, TOPMed rs202117167, gnomAD rs202117167, REVEL 0.07, CADD 22.00, Uncertain significance, not specified
- R65W (p.Arg65Trp), cosmic curated COSV54274, ExAC rs776401170, gnomAD rs776401170, REVEL 0.36, CADD 24.60
- V66A (p.Val66Ala), TOPMed rs1266456794, gnomAD rs1266456794, REVEL 0.30, CADD 22.50
- V66G (p.Val66Gly), cosmic curated COSV54278, TOPMed rs1266456794, gnomAD rs1266456794
- V66L (p.Val66Leu), 1000Genomes rs549540182, ExAC rs549540182, gnomAD rs549540182, REVEL 0.08, CADD 16.70
- V66M (p.Val66Met), cosmic curated COSV54277, 1000Genomes rs549540182, ExAC rs549540182, gnomAD rs549540182, REVEL 0.22, CADD 22.50
- W70G (p.Trp70Gly), TOPMed rs928742057, gnomAD rs928742057, REVEL 0.17, CADD 6.00, Uncertain significance, not specified
- W70R (p.Trp70Arg), TOPMed rs928742057, gnomAD rs928742057, REVEL 0.13, CADD 0.20
- C71G (p.Cys71Gly), gnomAD rs1243609576, REVEL 0.88, CADD 25.60
- C71R (p.Cys71Arg), gnomAD rs1243609576, REVEL 0.89, CADD 25.10
- C71Y (p.Cys71Tyr), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99535, Variant assessed as somatic; moderate impact.
- N72D (p.Asn72Asp), TOPMed rs1805587429
- S73G (p.Ser73Gly), TOPMed rs1182273420, gnomAD rs1182273420, REVEL 0.07, CADD 0.29
- S73N (p.Ser73Asn), ExAC rs745846835, gnomAD rs745846835, REVEL 0.18, CADD 6.96
- G74V (p.Gly74Val), cosmic curated COSV10636
- A76G (p.Ala76Gly), gnomAD rs1249907900
- A76T (p.Ala76Thr), cosmic curated COSV10806, gnomAD rs1341904721, REVEL 0.07, CADD 0.01
- Q77E (p.Gln77Glu), Ensembl rs1805586700, Uncertain significance, not specified
- C78* (p.Cys78Ter), gnomAD rs1339393400, CADD 36.00
- C78F (p.Cys78Phe), gnomAD rs1216428160
- H79Y (p.His79Tyr), Ensembl rs1805586192
- S80* (p.Ser80Ter), cosmic curated COSV54277, NCI-TCGA Cosmic COSV5427, NCI-TCGA Cosmic COSV9953, Variant assessed as somatic; high impact.
- S80L (p.Ser80Leu), cosmic curated COSV54277
- V81L (p.Val81Leu), cosmic curated COSV54275
- V81M (p.Val81Met), TOPMed rs1805585954
- P82S (p.Pro82Ser), ExAC rs777811623, TOPMed rs777811623, gnomAD rs777811623, REVEL 0.56, CADD 24.40
- P82T (p.Pro82Thr), ExAC rs777811623, TOPMed rs777811623, gnomAD rs777811623, REVEL 0.62, CADD 24.00
- V83G (p.Val83Gly), Ensembl rs1343677219
- V83I (p.Val83Ile), TOPMed rs1358829045, gnomAD rs1358829045, REVEL 0.14, CADD 6.73
- K84R (p.Lys84Arg), TOPMed rs1416061528, gnomAD rs1416061528, REVEL 0.20, CADD 0.14
- S85I (p.Ser85Ile), TOPMed rs1450445524, gnomAD rs1450445524, REVEL 0.27, CADD 21.30, Uncertain significance, not specified
- C86G (p.Cys86Gly), TOPMed rs1805551747
- C86Y (p.Cys86Tyr), NCI-TCGA Cosmic COSV5427, cosmic curated COSV54274, Variant assessed as somatic; moderate impact.
- S87R (p.Ser87Arg), ExAC rs751015695, TOPMed rs751015695, gnomAD rs751015695, REVEL 0.42, CADD 0.20
- E88K (p.Glu88Lys), ExAC rs764826571, TOPMed rs764826571, gnomAD rs764826571, REVEL 0.22, CADD 13.40
- F92L (p.Phe92Leu), NCI-TCGA TCGA novel, REVEL 0.35, CADD 13.20, Variant assessed as somatic; moderate impact.
- G94R (p.Gly94Arg), ExAC rs776079671, TOPMed rs776079671, gnomAD rs776079671, REVEL 0.58, CADD 23.60
- G95D (p.Gly95Asp), cosmic curated COSV54277
- T96A (p.Thr96Ala), cosmic curated COSV54276, REVEL 0.50, CADD 9.36
- T96I (p.Thr96Ile), TOPMed rs1445739162, gnomAD rs1445739162, REVEL 0.51, CADD 7.19
- T96P (p.Thr96Pro), Ensembl rs1587935390
- T96S (p.Thr96Ser), TOPMed rs1445739162, gnomAD rs1445739162, REVEL 0.33, CADD 4.73
- C97Y (p.Cys97Tyr), TOPMed rs1159656257, gnomAD rs1159656257, REVEL 0.83, CADD 23.90
- Q98R (p.Gln98Arg), ExAC rs768378966, gnomAD rs768378966, REVEL 0.32, CADD 0.04
- Q99K (p.Gln99Lys), cosmic curated COSV54277
- A100V (p.Ala100Val), ESP rs149424073, ExAC rs149424073, TOPMed rs149424073, gnomAD rs149424073, REVEL 0.49, CADD 23.50, Uncertain significance, not specified
- L101V (p.Leu101Val), TOPMed rs1325440261, gnomAD rs1325440261, REVEL 0.25, CADD 2.03, Uncertain significance, not specified
- D105E (p.Asp105Glu), gnomAD rs1805549123, REVEL 0.33, CADD 8.56
- D105N (p.Asp105Asn), ExAC rs3020630, REVEL 0.30, CADD 17.40
- V107E (p.Val107Glu), Ensembl rs112022591
- V107M (p.Val107Met), rs778893632, ClinGen CA4731407, ClinVar RCV004511672, ExAC rs778893632, REVEL 0.40, CADD 24.90, Uncertain significance, not specified
- C108* (p.Cys108Ter), NCI-TCGA Cosmic COSV9953, cosmic curated COSV99535, Variant assessed as somatic; high impact.
- C108R (p.Cys108Arg), gnomAD rs1471460909, REVEL 0.92, CADD 28.80
- Q109R (p.Gln109Arg), gnomAD rs1563258271, REVEL 0.32, CADD 22.10
- C110R (p.Cys110Arg), cosmic curated COSV10806
- E112K (p.Glu112Lys), rs1055213581, NCI-TCGA Cosmic COSV5427, cosmic curated COSV54274, TOPMed rs1055213581, REVEL 0.24, CADD 19.70, Variant assessed as somatic; moderate impact.
- G113E (p.Gly113Glu), ExAC rs755255849, gnomAD rs755255849, REVEL 0.84, CADD 25.80
- G113R (p.Gly113Arg), ExAC rs781218495, gnomAD rs781218495, REVEL 0.79, CADD 24.60
- G113V (p.Gly113Val), ExAC rs755255849, gnomAD rs755255849
- A115T (p.Ala115Thr), TOPMed rs1352589038
- A115V (p.Ala115Val), TOPMed rs1229221305
- G116E (p.Gly116Glu), TOPMed rs1265270754, gnomAD rs1265270754, REVEL 0.87, CADD 25.20
- C119Y (p.Cys119Tyr), ExAC rs751767279, gnomAD rs751767279, REVEL 0.77, CADD 26.40
- E120Q (p.Glu120Gln), gnomAD rs1223819876, REVEL 0.24, CADD 26.90
- D122H (p.Asp122His), ExAC rs780540773, TOPMed rs780540773, gnomAD rs780540773, REVEL 0.51, CADD 35.00
- D122V (p.Asp122Val), cosmic curated COSV10958
- R124G (p.Arg124Gly), TOPMed rs1805533032, REVEL 0.20, CADD 8.79
- R124S (p.Arg124Ser), cosmic curated COSV99535
- R124T (p.Arg124Thr), ExAC rs768663768, TOPMed rs768663768, gnomAD rs768663768, REVEL 0.09, CADD 0.84
- A125D (p.Ala125Asp), gnomAD rs1424113144, REVEL 0.11, CADD 16.30
- T126K (p.Thr126Lys), ExAC rs747219199, gnomAD rs747219199, REVEL 0.12, CADD 7.80
- T126M (p.Thr126Met), ExAC rs747219199, gnomAD rs747219199, REVEL 0.14, CADD 14.30, Uncertain significance, not specified
- C127* (p.Cys127Ter), ESP rs373564770, ExAC rs373564770, TOPMed rs373564770, gnomAD rs373564770, CADD 35.00
- C127S (p.Cys127Ser), ESP rs376455032, ExAC rs376455032, TOPMed rs376455032, gnomAD rs376455032, REVEL 0.87, CADD 25.30
- Y128* (p.Tyr128Ter), 1000Genomes rs114679748, ExAC rs114679748, TOPMed rs114679748, gnomAD rs114679748, CADD 32.00
- Y128C (p.Tyr128Cys), ESP rs375775114, ExAC rs375775114, gnomAD rs375775114, REVEL 0.45, CADD 24.80
- E129D (p.Glu129Asp), gnomAD rs1207831505
- E129K (p.Glu129Lys), rs887965470, ClinGen CA175957939, ClinVar RCV003488267, Ensembl rs887965470, REVEL 0.21, CADD 0.01, Uncertain significance, not provided
- D130V (p.Asp130Val), ExAC rs754352757
- Q131E (p.Gln131Glu), ExAC rs763647679, gnomAD rs763647679, REVEL 0.05, CADD 2.12
- G132D (p.Gly132Asp), ExAC rs755649494, TOPMed rs755649494, gnomAD rs755649494, REVEL 0.71, CADD 24.10, Uncertain significance, not specified
- G132S (p.Gly132Ser), cosmic curated COSV54274
- G132V (p.Gly132Val), ExAC rs755649494, TOPMed rs755649494, gnomAD rs755649494
- I133F (p.Ile133Phe), Ensembl rs1805530557
- I133V (p.Ile133Val), Ensembl rs1805530557, REVEL 0.04, CADD 1.10
- S134T (p.Ser134Thr), ExAC rs752282051, gnomAD rs752282051, REVEL 0.13, CADD 7.82
- Y135* (p.Tyr135Ter), gnomAD rs1338649781, CADD 31.00
- Y135C (p.Tyr135Cys), Ensembl rs1587934950
- R136M (p.Arg136Met), cosmic curated COSV99535
- R136S (p.Arg136Ser), rs8178747, UniProt VAR 038732, 1000Genomes rs8178747, ESP rs8178747, REVEL 0.53, CADD 21.90
- G137C (p.Gly137Cys), cosmic curated COSV99534
- G137D (p.Gly137Asp), TOPMed rs1406253336, gnomAD rs1406253336, REVEL 0.88, CADD 24.40
- G137S (p.Gly137Ser), gnomAD rs796143433, REVEL 0.79, CADD 24.50
- T138A (p.Thr138Ala), gnomAD rs1357973457, REVEL 0.30, CADD 23.00
- T138M (p.Thr138Met), rs759282035, NCI-TCGA Cosmic COSV9953, cosmic curated COSV99535, ExAC rs759282035, REVEL 0.27, CADD 17.10, Variant assessed as somatic; moderate impact.
- W139* (p.Trp139Ter), cosmic curated COSV99535
- W139C (p.Trp139Cys), cosmic curated COSV99535
Public PLAT analysis runs
- PLAT analysis run — PLAT (966 variants) — completed 2026-08-21